You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Albumin-Bound Paclitaxel

Showing 26 - 50 of 4,750
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Breast Cancer Trial in Beijing (Inetetamab, Toripalimab, Albumin-Bound Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Beijing, China
      Cancer Hospital Chinese Academy Of Medical Sciences
    Mar 14, 2022

    Triple-negative Breast Cancer Trial in Bengbu (Albumin-Bound Paclitaxel, Apatinib Mesylate, Bevacizumab)

    Recruiting
    • Triple-negative Breast Cancer
    • Albumin-Bound Paclitaxel
    • +2 more
    • Bengbu, Anhui, China
      Department of Medical Oncology, First Affiliated Hospital of Ben
    Mar 15, 2022

    Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

    Not yet recruiting
    • Advanced Solid Tumor
    • JS015
    • +10 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 17, 2023

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

    Not yet recruiting
    • Solid Tumor, Adult
    • EOC202
    • albumin-bound paclitaxel
    • (no location specified)
    Apr 7, 2022

    Cervical Cancer Trial in Beijing (HLX10+Albumin-Bound Paclitaxel)

    Active, not recruiting
    • Cervical Cancer
    • HLX10+Albumin-Bound Paclitaxel
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 4, 2022

    Advanced Urothelial Carcinoma Trial in Beijing (anti-PD-L1 antibody, albumin bound paclitaxel)

    Active, not recruiting
    • Advanced Urothelial Carcinoma
    • anti-PD-L1 antibody
    • albumin bound paclitaxel
    • Beijing, Beijing, China
      Beijing Tumor Hospital
    Jan 20, 2022

    Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Anti-PD-1 antibody camrelizumab,

    Recruiting
    • Recurrent Cervical Carcinoma
    • +5 more
    • Anti-PD-1 antibody camrelizumab
    • Albumin-bound paclitaxel
    • Beijing, Beijing, China
      Lei Li
    Mar 12, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jan 13, 2023

    Soft Tissue Sarcoma Trial in Zhengzhou (Albumin-Bound Paclitaxel, Camrelizumab)

    Recruiting
    • Soft Tissue Sarcoma
    • Zhengzhou, Henan, China
      Department of Bone and Soft Tissue, Henan Cancer Hospital
    Jan 13, 2022

    Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)

    Recruiting
    • Pancreatic Cancer
    • Shanghai, Shanghai, China
      Renji Hospital of Shanghai Jiaotong University School of Medicin
    Apr 23, 2023

    Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

    Suspended
    • Distal Bile Duct Adenocarcinoma
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai chest hospital
    Sep 24, 2023

    Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

    Not yet recruiting
    • Locally Advanced Unresectable Esophageal Squamous Carcinoma
    • Docetaxel for Injection (Albumin-bound)
    • +4 more
    • Jinan, Shandong, China
    • +1 more
    Nov 16, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +4 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +3 more
    • (no location specified)
    Jun 28, 2022

    Advanced Breast Cancer Trial in Shijia Zhuang (SYHX2011, Paclitaxel for injection (albumin-bound))

    Not yet recruiting
    • Advanced Breast Cancer
    • SYHX2011
    • Paclitaxel for injection (albumin-bound)
    • Shijia Zhuang, Hebei, China
      The Fourth Hospital of Hebei Medical University
    Feb 22, 2023

    Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

    Not yet recruiting
    • Esophageal Carcinoma
    • Neoadjuvant Therapy
    • (no location specified)
    Aug 16, 2023

    Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in China (Tislelizumab, Albumin-Bound Paclitaxel,

    Recruiting
    • Oral Squamous Cell Carcinoma
    • Oropharyngeal Squamous Cell Carcinoma
    • Beijing, Beijing, China
    • +13 more
    Aug 22, 2023

    Advanced Solid Tumor Trial (CVL218)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Oct 9, 2023

    Gastric Cancer Trial in Wuhan (Albumin-bound Paclitaxel plus S-1, Oxaliplatin plus S-1)

    Recruiting
    • Gastric Cancer
    • Albumin-bound Paclitaxel plus S-1
    • Oxaliplatin plus S-1
    • Wuhan, Hubei, China
      Tongji hospital of Tongji Medical College, Huazhong University o
    Jan 3, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin
    • (no location specified)
    Dec 29, 2021

    Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

    Active, not recruiting
    • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 15, 2022

    Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

    Recruiting
    • Breast Cancer
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jun 28, 2022